Deqing County Launches Three Morinda Officinalis Health Products

What changed

Deqing County in Guangdong presented three new Morinda officinalis products at a Beijing promotion event: 巴戟骨宝颗粒, 巴戟保元口服液 and 巴戟健阳口服液. The launch marks an effort to move the county’s southern medicinal-herb industry beyond raw materials and into branded health products. In 2025, Deqing’s southern medicinal-herb sector covered 768,100 mu, produced 303,600 tonnes and generated 4.074 billion yuan.

Why it matters

Deqing is trying to capture more value from what it grows. Its four main southern medicines are cinnamon, Morinda officinalis, fleeceflower root and fingered citron. Morinda officinalis has been cultivated there for more than 900 years, and its long history now supports a modern push built around branding, standardisation and market access.

That shift changes the commercial question. Deqing is no longer presenting medicinal herbs only as agricultural output; it is presenting them as finished products aimed at everyday health management. The three launches, released through the Lingnan Medicinal Herb Box platform, are the clearest sign yet of that strategy.

The likely test is whether the new products can turn local recognition into repeat demand. The reporting gives no sales figures, pricing, production capacity, regulatory status or clinical evidence, so the launch shows ambition rather than market success. Deqing officials say they want the products to reach markets across China and internationally.